Clinical Trial Update: TAK-875 Glimepiride Drug-Interaction Study [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study evaluating potential drug interaction between TAK-875 (fasiglifam) and glimepiride has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glimepiride (glimepiride)
• TAK-875 (fasiglifam)

Snippet

Sponsor: Takeda | Conditions: Pharmacokinetics | Phase 1 | Status: COMPLETED